North America,Central/South America,Western Europe,Eastern Europe,Australasia,Asia,Middle East,Africa
Product Description
In-house Standards
AI Product Description
*The following content is generated by AI and is for reference only.
<h3>Overview</h3>
<p>Dabrafenib (CAS 1195765-45-7) is a selective BRAF V600E inhibitor used in oncology. Its synthesis involves advanced organic coupling and purification <strong>processes</strong>. The molecular formula is C20H18ClN5O.</p>
<h3>Application</h3>
<ul>
<li>Treatment of unresectable or metastatic melanoma with BRAF V600 mutations.</li>
<li>Combination therapy with MEK inhibitors for non-small cell lung cancer.</li>
<li>Research applications in targeted kinase inhibition studies.</li>
</ul>
<h3>Precautions</h3>
<p>Contraindicated in patients with wild-type BRAF tumors. Requires storage below 25°C in dry conditions. Strict occupational safety protocols are mandatory due to cytotoxicity risks during handling.</p>